Clinical behavior of recurrent hormone receptor–positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1‐98 clinical trial

Author:

Leone Jose P.1ORCID,Cole Bernard F.2,Regan Meredith M.3,Thürlimann Beat45,Coates Alan S.6,Rabaglio Manuela789,Giobbie‐Hurder Anita10,Gelber Richard D.10,Ejlertsen Bent11,Harvey Vernon J.12,Neven Patrick13,Láng Istvan14,Bonnefoi Herve15,Wardley Andrew16,Goldhirsch Aron517,Di Leo Angelo18,Colleoni Marco17,Vaz‐Luis Ines19,Lin Nancy U.1

Affiliation:

1. Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts

2. Department of Mathematics and Statistics University of Vermont Burlington Vermont

3. International Breast Cancer Study Group Statistical Center Division of Biostatistics Dana‐Farber Cancer Institute, Harvard Medical School Boston Massachusetts

4. Kantonsspital St. Gallen St. Gallen Switzerland

5. International Breast Cancer Study Group and Swiss Group for Clinical Cancer Research Bern Switzerland

6. International Breast Cancer Study Group and University of Sydney Sydney New South Wales Australia

7. International Breast Cancer Study Group Coordinating Center Bern Switzerland

8. Department of Medical Oncology, Inselspital Bern University HospitalUniversity of Bern Bern Switzerland

9. Swiss Group for Clinical Cancer Research Bern Switzerland

10. Division of Biostatistics Dana‐Farber Cancer Institute, Harvard Medical School Boston Massachusetts

11. Department of Oncology Centre for Cancer and Organ Diseases University of Copenhagen Copenhagen Denmark

12. Regional Cancer and Blood Service Auckland City Hospital Auckland New Zealand

13. Department of Oncology Universitair Ziekenhuis Leuven Leuven Belgium

14. Oncology Clinic Istenhegyi Géndiagnosztika Private Health Center Budapest Hungary

15. Department of Medical Oncology Bergonié Institute Bordeaux France

16. National Institute for Health Research Manchester Clinical Research Facility at the Christie National Health Service Foundation Trust, Manchester Academic Health Science Centre and Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine and Health, University of Manchester Manchester United Kingdom

17. European Institute of OncologyIRCCS Milan Italy

18. Hospital of Prato–AUSL Toscana Centro Prato Italy

19. National Institute of Health and Medical Research Unit 981Gustave Roussy Institute Villejuif France

Funder

International Breast Cancer Research Foundation

Oncosuisse

Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung

Novartis

Cancer Council Western Australia

Vetenskapsrådet

Cancerfonden

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3